Delivery Order SPE2DB20D3505-SPE2DB22FU0M7
- Not listed
- This federal contract award is for the delivery of VIMPAT 150 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,817.52, is for the delivery of Vimpat 50 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for Cencora, Inc....
- This federal contract award, valued at $1,936.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,274.41 firm fixed-price delivery order is for the supply of VIMPAT 100 mg tablets, a prescription medication used to treat epilepsy. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, valued at $1,678.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $1,759.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the government. The contract has a completion date of May 7, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This federal contract award, valued at $2,854.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VIMPAT 150 MG TABLET 60S, a pharmaceutical product, with a completion date of January 13, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $1,040.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of VIMPAT 200 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $1,281.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, with a performance period ending on April 21, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FU0M7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, valued at $1,920.50, is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication. The contract is a delivery order and has a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/18/22 |